Weight-Loss Injections Show Promise for Obese Children Aged 6-11
Summarized from Israel National News by baba
A study found that weight-loss injections like Wegovy significantly reduced obesity in children aged 6-11, with about 40% no longer meeting obesity criteria after 68 weeks. The drug showed an average 17.4% BMI reduction without impacting growth, though side effects were reported. Novo Nordisk plans to seek expanded FDA approval for younger children.
The story in 6 lines · by baba
- Weight-loss injections like Wegovy showed significant obesity reduction in children aged 6-11.
- About 40% of children on Wegovy no longer met obesity criteria after 68 weeks.
- The treatment resulted in an average 17.4% body mass index reduction.
- No adverse effects on children's growth or development were observed.
- Novo Nordisk plans to seek expanded FDA approval for the drug's use in younger children.
- Three Israeli medical centers participated in the study.
Israel National News publishes in English. The key points are summarized above. Read Israel National News’s full report from the link at the top of the page.
Mentioned
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Centre 2Right 2
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
